Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells

The molecular nature of calcium (Ca 2+ )-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca 2+ ent...

Full description

Saved in:
Bibliographic Details
Published inCell death & disease Vol. 1; no. 9; p. e75
Main Authors Flourakis, M, Lehen'kyi, V, Beck, B, Raphaël, M, Vandenberghe, M, Abeele, F V, Roudbaraki, M, Lepage, G, Mauroy, B, Romanin, C, Shuba, Y, Skryma, R, Prevarskaya, N
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.09.2010
Springer Nature B.V
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The molecular nature of calcium (Ca 2+ )-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca 2+ entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca 2+ influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor α , and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca 2+ -selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells.
AbstractList The molecular nature of calcium (Ca(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca(2+) entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca(2+) influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor α, and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca(2+)-selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells.
The molecular nature of calcium (Ca2+ )-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca2+ entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca2+ influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor α, and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca 2+ -selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells.
The molecular nature of calcium (Ca super(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca super(2+) entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca super(2+) influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor alpha , and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca super(2+)-selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells.
The molecular nature of calcium (Ca 2+ )-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca 2+ entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca 2+ influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor α , and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca 2+ -selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells.
The molecular nature of calcium (Ca(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca(2+) entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca(2+) influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor α, and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca(2+)-selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells.The molecular nature of calcium (Ca(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of debate. Here, we show that the recently identified Orai1 protein represents the major molecular component of endogenous store-operated Ca(2+) entry (SOCE) in human prostate cancer (PCa) cells, and constitutes the principal source of Ca(2+) influx used by the cell to trigger apoptosis. The downregulation of Orai1, and consequently SOCE, protects the cells from diverse apoptosis-inducing pathways, such as those induced by thapsigargin (Tg), tumor necrosis factor α, and cisplatin/oxaliplatin. The transfection of functional Orai1 mutants, such as R91W, a selectivity mutant, and L273S, a coiled-coil mutant, into the cells significantly decreased both SOCE and the rate of Tg-induced apoptosis. This suggests that the functional coupling of STIM1 to Orai1, as well as Orai1 Ca(2+)-selectivity as a channel, is required for its pro-apoptotic effects. We have also shown that the apoptosis resistance of androgen-independent PCa cells is associated with the downregulation of Orai1 expression as well as SOCE. Orai1 rescue, following Orai1 transfection of steroid-deprived cells, re-established the store-operated channel current and restored the normal rate of apoptosis. Thus, Orai1 has a pivotal role in the triggering of apoptosis, irrespective of apoptosis-inducing stimuli, and in the establishment of an apoptosis-resistant phenotype in PCa cells.
Author Shuba, Y
Lehen'kyi, V
Lepage, G
Vandenberghe, M
Mauroy, B
Skryma, R
Romanin, C
Abeele, F V
Roudbaraki, M
Raphaël, M
Beck, B
Flourakis, M
Prevarskaya, N
Author_xml – sequence: 1
  givenname: M
  surname: Flourakis
  fullname: Flourakis, M
  organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL), 7Current address: Center for Sleep and Circadian Biology, Department of Neurobiology and Physiology, Northwestern University, 2205 Tech Drive, #2-160, Evanston, IL 60208, USA
– sequence: 2
  givenname: V
  surname: Lehen'kyi
  fullname: Lehen'kyi, V
  organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL)
– sequence: 3
  givenname: B
  surname: Beck
  fullname: Beck, B
  organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL)
– sequence: 4
  givenname: M
  surname: Raphaël
  fullname: Raphaël, M
  organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL)
– sequence: 5
  givenname: M
  surname: Vandenberghe
  fullname: Vandenberghe, M
  organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL)
– sequence: 6
  givenname: F V
  surname: Abeele
  fullname: Abeele, F V
  organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL)
– sequence: 7
  givenname: M
  surname: Roudbaraki
  fullname: Roudbaraki, M
  organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL)
– sequence: 8
  givenname: G
  surname: Lepage
  fullname: Lepage, G
  organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL)
– sequence: 9
  givenname: B
  surname: Mauroy
  fullname: Mauroy, B
  organization: Université Catholique de Lille, Service d'Urologie
– sequence: 10
  givenname: C
  surname: Romanin
  fullname: Romanin, C
  organization: Institute for Biophysics, Johannes Kepler Universität Linz
– sequence: 11
  givenname: Y
  surname: Shuba
  fullname: Shuba, Y
  organization: Bogomoletz Institute of Physiology and International Center of Molecular Physiology NASU
– sequence: 12
  givenname: R
  surname: Skryma
  fullname: Skryma, R
  organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL)
– sequence: 13
  givenname: N
  surname: Prevarskaya
  fullname: Prevarskaya, N
  email: Natacha.Prevarskaya@univ-lille1.fr
  organization: INSERM U1003, Equipe labellisée par la Ligue Nationale contre le cancer, Université des Sciences et Technologies de Lille (USTL)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21364678$$D View this record in MEDLINE/PubMed
https://hal.science/hal-04122793$$DView record in HAL
BookMark eNp9kktv1DAQgC1UREvpkSuyxAF6yOLHOnYulaoKWqSVeundcpxJ4yprB9up1H-Pw5ZqWQE--DHzzXheb9GRDx4Qek_JihKuvtiuc2nFSHkL9gqdMLKm1Vqp5mjvfozOUnogZXFOmKjfoGNGeb2upTpB9jYaR7ENPkfXzhkSzgHnATCkbNrRpWELPuPQY-OxmcKUQ3KpilD2bIpmGsCH_DQBdh5PMRRpBmyNtxCxhXFM79Dr3owJzp7PU3T37evd1U21ub3-fnW5qaxgJFctZSBb2nbQ14SBFUSKthbC1EzJHiRrawVgbctkxxTrqGpa2XdSgeo4lfwUXezcTnO7hc6WsKMZ9RTd1sQnHYzTf2q8G_R9eNSccMbXi4PznYPhwOzmcqMXWakoY7Lhj7Swn54_i-HHXGqlty4t2RoPYU5aiZKTJIwU8vN_SSob0tS0Fk1BPx6gD2GOvtSsUKoWvBFMFOrDfp4vkf5uagGqHWBLN1KE_gWhRC9zo3_NjV7mRgtWeH7AW1ea6JaZMG78p9VqZ5WKd38PcS_Yvxr8BCbg12k
CitedBy_id crossref_primary_10_1016_j_apsb_2016_11_001
crossref_primary_10_1016_j_bbamem_2014_01_019
crossref_primary_10_3390_toxics6030034
crossref_primary_10_3390_cells11081332
crossref_primary_10_3390_cancers12092351
crossref_primary_10_3892_ol_2016_5469
crossref_primary_10_1371_journal_pone_0177484
crossref_primary_10_1002_jcb_24020
crossref_primary_10_1016_j_tcb_2022_07_004
crossref_primary_10_1016_j_bbamcr_2023_119532
crossref_primary_10_1007_s00424_013_1254_8
crossref_primary_10_1111_1440_1681_12900
crossref_primary_10_1016_j_humpath_2015_09_042
crossref_primary_10_1098_rstb_2013_0097
crossref_primary_10_1042_BSR20110062
crossref_primary_10_1074_jbc_M114_548602
crossref_primary_10_3390_biom11020229
crossref_primary_10_1007_s10059_013_2268_7
crossref_primary_10_1016_j_ceca_2019_102109
crossref_primary_10_18632_aging_100481
crossref_primary_10_1016_j_ceca_2018_09_005
crossref_primary_10_4049_jimmunol_1402942
crossref_primary_10_1038_s41420_019_0212_4
crossref_primary_10_1016_j_bbrc_2014_04_064
crossref_primary_10_4161_chan_24302
crossref_primary_10_1016_j_bbamcr_2014_02_012
crossref_primary_10_1152_physrev_00044_2016
crossref_primary_10_3390_biomedicines8060169
crossref_primary_10_1016_j_ceca_2018_07_011
crossref_primary_10_1371_journal_pone_0086089
crossref_primary_10_1186_s12935_020_01192_0
crossref_primary_10_1016_j_ceca_2019_102061
crossref_primary_10_1556_2060_2021_00137
crossref_primary_10_1096_fj_12_213801
crossref_primary_10_1016_j_ctrv_2013_07_008
crossref_primary_10_1038_onc_2012_481
crossref_primary_10_2147_IJN_S440419
crossref_primary_10_1080_23808993_2020_1803062
crossref_primary_10_3390_ijms23031763
crossref_primary_10_1038_nrc3105
crossref_primary_10_1111_jcmm_17516
crossref_primary_10_1098_rstb_2013_0108
crossref_primary_10_1098_rstb_2013_0109
crossref_primary_10_1016_j_snb_2019_03_084
crossref_primary_10_1016_j_bcp_2023_115955
crossref_primary_10_3390_cells10051246
crossref_primary_10_3390_cancers11070899
crossref_primary_10_1161_ATVBAHA_116_307869
crossref_primary_10_3390_ijms22010004
crossref_primary_10_1074_jbc_M117_796920
crossref_primary_10_3390_cancers15010101
crossref_primary_10_1016_j_bcp_2019_08_005
crossref_primary_10_1007_s11427_014_4774_3
crossref_primary_10_1515_bmc_2022_0012
crossref_primary_10_1096_fj_202002031RR
crossref_primary_10_1007_s00285_023_02033_0
crossref_primary_10_1016_j_bbrc_2011_09_081
crossref_primary_10_1074_jbc_R112_343061
crossref_primary_10_1016_j_phrs_2019_104282
crossref_primary_10_3390_cancers11040457
crossref_primary_10_15407_ubj90_03_041
crossref_primary_10_4161_chan_24960
crossref_primary_10_1016_j_bbrc_2019_03_025
crossref_primary_10_3390_cells10050966
crossref_primary_10_1016_j_bbamem_2014_10_030
crossref_primary_10_1016_j_bbrc_2011_09_110
crossref_primary_10_1007_s10571_020_00873_8
crossref_primary_10_1016_j_dci_2019_103601
crossref_primary_10_1517_14728222_2013_741594
crossref_primary_10_1016_j_jbior_2017_11_006
crossref_primary_10_1016_j_molcel_2020_04_017
crossref_primary_10_1016_j_ceca_2017_06_002
crossref_primary_10_3390_cells10061317
crossref_primary_10_1038_s41585_023_00738_x
crossref_primary_10_1111_pcmr_12222
crossref_primary_10_3390_cancers13122947
crossref_primary_10_3390_membranes10120425
crossref_primary_10_1016_j_jsbmb_2014_05_006
crossref_primary_10_1152_ajpcell_00064_2015
crossref_primary_10_1152_ajpcell_00364_2015
crossref_primary_10_1038_cddis_2015_23
crossref_primary_10_3390_cells11010057
crossref_primary_10_1007_s12035_018_1112_y
crossref_primary_10_3390_cancers11030376
crossref_primary_10_1038_srep11754
crossref_primary_10_3390_ijms19041237
crossref_primary_10_1002_mc_22324
crossref_primary_10_1016_j_ceca_2018_12_003
crossref_primary_10_1002_cam4_2756
crossref_primary_10_1038_s41420_023_01703_8
crossref_primary_10_1080_19420862_2018_1548232
crossref_primary_10_3390_ijms21093218
crossref_primary_10_1152_ajpcell_00249_2011
crossref_primary_10_3390_cancers12030750
crossref_primary_10_1016_j_bpj_2015_08_006
crossref_primary_10_3389_fragi_2022_876785
crossref_primary_10_1111_febs_12246
crossref_primary_10_3389_fphar_2020_00968
crossref_primary_10_3390_ijms23105555
crossref_primary_10_1016_j_ceca_2023_102716
crossref_primary_10_3390_biomedicines9091077
crossref_primary_10_1016_s10059_013_2268_7
crossref_primary_10_1016_j_ceca_2011_04_002
crossref_primary_10_1161_CIRCRESAHA_122_321041
crossref_primary_10_1016_j_ceca_2022_102673
crossref_primary_10_18632_oncotarget_2035
crossref_primary_10_3390_cancers15061825
crossref_primary_10_3390_cells12182225
crossref_primary_10_3390_jpm12020210
crossref_primary_10_1007_s11427_016_5087_5
crossref_primary_10_1016_j_jsps_2022_12_009
crossref_primary_10_1002_ijc_29840
crossref_primary_10_1016_j_ceca_2022_102554
crossref_primary_10_1073_pnas_1218247109
crossref_primary_10_1016_j_bbamcr_2015_10_003
crossref_primary_10_1016_j_canlet_2018_06_006
crossref_primary_10_1016_j_ceca_2013_01_001
crossref_primary_10_1038_cddis_2011_89
crossref_primary_10_3390_cancers10090331
crossref_primary_10_3390_biom14040417
crossref_primary_10_3389_fcell_2020_622215
crossref_primary_10_1038_nrc_2017_18
crossref_primary_10_1039_D1SM01618K
crossref_primary_10_1038_cddis_2012_2
crossref_primary_10_3390_ijms231810687
crossref_primary_10_1016_j_bbamcr_2015_12_009
crossref_primary_10_1111_febs_12475
crossref_primary_10_20517_cdr_2023_145
crossref_primary_10_1002_pros_23904
crossref_primary_10_1007_s40610_017_0072_8
crossref_primary_10_5306_wjco_v14_i12_549
crossref_primary_10_1016_j_ccr_2014_04_025
crossref_primary_10_1007_s00249_016_1171_9
crossref_primary_10_3389_fnmol_2021_757515
crossref_primary_10_1002_mc_20843
crossref_primary_10_1152_ajpcell_00136_2011
crossref_primary_10_1073_pnas_1413409111
crossref_primary_10_18632_oncotarget_9755
crossref_primary_10_1016_j_bbamem_2015_06_009
crossref_primary_10_52601_bpr_2024_230023
crossref_primary_10_1186_2193_1801_2_54
crossref_primary_10_1113_JP271141
crossref_primary_10_1089_bioe_2022_0013
crossref_primary_10_1016_j_ceca_2018_03_002
crossref_primary_10_1155_2023_4732242
crossref_primary_10_1038_s41418_017_0007_1
crossref_primary_10_1016_j_bbamcr_2015_11_032
crossref_primary_10_1016_j_bbrc_2016_06_032
crossref_primary_10_1016_j_bbamcr_2015_11_033
crossref_primary_10_1007_s10059_013_0073_2
crossref_primary_10_18632_oncotarget_1903
crossref_primary_10_1002_emmm_201303129
crossref_primary_10_1016_j_gendis_2024_101281
crossref_primary_10_3389_fmolb_2022_1041674
crossref_primary_10_1016_j_coph_2016_03_002
crossref_primary_10_1111_j_1582_4934_2011_01395_x
Cites_doi 10.1038/ncb1995
10.1038/onc.2008.308
10.1096/fj.05-5254fje
10.1016/j.ceca.2007.03.007
10.1074/jbc.M708898200
10.1038/ncb1731
10.1038/sj.cdd.4401375
10.1111/j.1469-7793.2000.00071.x
10.1096/fj.09-131128
10.1002/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G
10.1103/PhysRevE.77.016604
10.1074/jbc.M509110200
10.1158/0008-5472.CAN-05-2394
10.1038/ncb1435
10.1074/jbc.M804942200
10.1093/bioinformatics/bti473
10.1002/pros.10133
10.1016/S1535-6108(02)00034-X
10.1038/sj.onc.1210545
10.1126/science.1081208
10.1093/annonc/12.suppl_2.S141
10.1038/nature04147
10.1016/j.ccr.2008.12.019
10.1006/meth.2001.1262
10.1038/cdd.2008.123
10.1074/jbc.M310206200
10.1073/pnas.0611692104
10.1056/NEJMoa040720
10.4161/cbt.4.1.1505
10.1124/mol.59.4.657
10.1016/j.bbrc.2004.08.037
ContentType Journal Article
Copyright The Author(s) 2010
Copyright Nature Publishing Group Sep 2010
Distributed under a Creative Commons Attribution 4.0 International License
Copyright © 2010 Macmillan Publishers Limited 2010 Macmillan Publishers Limited
Copyright_xml – notice: The Author(s) 2010
– notice: Copyright Nature Publishing Group Sep 2010
– notice: Distributed under a Creative Commons Attribution 4.0 International License
– notice: Copyright © 2010 Macmillan Publishers Limited 2010 Macmillan Publishers Limited
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7TO
H94
7X8
1XC
5PM
DOI 10.1038/cddis.2010.52
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
Hyper Article en Ligne (HAL)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts


MEDLINE - Academic

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Orai1 in apoptosis resistance of prostate cancer
EISSN 2041-4889
EndPage e75
ExternalDocumentID PMC3032347
oai_HAL_hal_04122793v1
4043799051
21364678
10_1038_cddis_2010_52
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
3V.
53G
5VS
70F
7X7
88A
88I
8FE
8FH
8FI
8FJ
AAJSJ
ABAWZ
ABUWG
ACGFS
ACSMW
ADBBV
ADRAZ
AENEX
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CAG
CCPQU
COF
DIK
DWQXO
E3Z
EBLON
EBS
EJD
EMOBN
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
HZ~
IPNFZ
KQ8
LK8
M0L
M2P
M48
M7P
M~E
NAO
O5R
O5S
O9-
OK1
PIMPY
PQQKQ
PROAC
RIG
RNT
RPM
SNYQT
TR2
UKHRP
W2D
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
K9.
PKEHL
PQEST
PQGLB
PQUKI
PRINS
Q9U
7TO
H94
7X8
1XC
5PM
ID FETCH-LOGICAL-c520t-b12e7b1bdef602ec5075b655a6287fe72b68eeccb27d282d189b7fd78e8d3173
IEDL.DBID M48
ISSN 2041-4889
IngestDate Thu Aug 21 14:05:31 EDT 2025
Fri May 09 12:26:28 EDT 2025
Thu Jul 10 19:22:19 EDT 2025
Fri Jul 11 11:00:25 EDT 2025
Wed Aug 13 03:12:32 EDT 2025
Thu Jan 02 22:08:15 EST 2025
Tue Jul 01 01:10:32 EDT 2025
Thu Apr 24 23:12:39 EDT 2025
Fri Feb 21 02:37:08 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords prostate cancer
apoptosis resistance
Orai channels
store-operated calcium entry
Language English
License Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c520t-b12e7b1bdef602ec5075b655a6287fe72b68eeccb27d282d189b7fd78e8d3173
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC3032347
These authors contributed equally to this work.
Current address: Center for Sleep and Circadian Biology, Department of Neurobiology and Physiology, Northwestern University, 2205 Tech Drive, #2-160, Evanston, IL 60208, USA.
OpenAccessLink https://www.proquest.com/docview/1786539525?pq-origsite=%requestingapplication%
PMID 21364678
PQID 1786539525
PQPubID 2041963
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3032347
hal_primary_oai_HAL_hal_04122793v1
proquest_miscellaneous_855207020
proquest_miscellaneous_1790961659
proquest_journals_1786539525
pubmed_primary_21364678
crossref_primary_10_1038_cddis_2010_52
crossref_citationtrail_10_1038_cddis_2010_52
springer_journals_10_1038_cddis_2010_52
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-09-01
PublicationDateYYYYMMDD 2010-09-01
PublicationDate_xml – month: 09
  year: 2010
  text: 2010-09-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Cell death & disease
PublicationTitleAbbrev Cell Death Dis
PublicationTitleAlternate Cell Death Dis
PublicationYear 2010
Publisher Nature Publishing Group UK
Springer Nature B.V
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Springer Nature B.V
– name: Nature Publishing Group
References Denmeade, Lin, Isaacs (CR18) 1996; 28
Smyth, Petranka, Boyles, DeHaven, Fukushima, Johnson (CR30) 2009; 11
Denmeade, Isaacs (CR22) 2005; 4
Muik, Frischauf, Derler, Fahrner, Bergsmann, Eder (CR12) 2008; 283
Livak, Schmittgen (CR32) 2001; 25
Gwack, Feske, Srikanth, Hogan, Rao (CR16) 2007; 42
Yang, Zhang, Huang (CR28) 2009; 15
Vanden Abeele, Skryma, Shuba, Van Coppenolle, Slomianny, Roudbaraki (CR14) 2002; 1
Fixemer, Remberger, Bonkhoff (CR5) 2002; 53
Bonkhoff (CR19) 2001; 12
Peinelt, Vig, Koomoa, Beck, Nadler, Koblan-Huberson (CR27) 2006; 8
Zhang, Yu, Roos, Kozak, Deerinck, Ellisman (CR10) 2005; 437
Vanoverberghe, Vanden Abeele, Mariot, Lepage, Roudbaraki, Bonnal (CR9) 2004; 11
Potier, Gonzalez, Motiani, Abdullaev, Bisaillon, Singer (CR29) 2009; 23
Norberg, Gogvadze, Ott, Horn, Uhlen, Orrenius (CR4) 2008; 15
Raffo, Perlman, Chen, Day, Streitman, Buttyan (CR6) 1995; 55
Nawrocki, Carew, Dunner, Boise, Chiao, Huang (CR25) 2005; 65
Gonzalez, Fuertes, Alonso, Perez (CR23) 2001; 59
Skryma, Mariot, Bourhis, Coppenolle, Shuba, Vanden Abeele (CR8) 2000; 527
Di Sano, Ferraro, Tufi, Achsel, Piacentini, Cecconi (CR24) 2006; 281
Nantermet, Xu, Yu, Hodor, Holder, Adamski (CR20) 2004; 279
Scorrano, Oakes, Opferman, Cheng, Sorcinelli, Pozzan (CR1) 2003; 300
Cartharius, Frech, Grote, Klocke, Haltmeier, Klingenhoff (CR21) 2005; 21
Prevarskaya, Skryma, Shuba (CR2) 2004; 322
Ng, di Capite, Singaravelu, Parekh (CR13) 2008; 283
Stiber, Hawkins, Zhang, Wang, Burch, Graham (CR17) 2008; 10
Lehen'kyi, Flourakis, Skryma, Prevarskaya (CR31) 2007; 26
Flourakis, Van Coppenolle, Lehen'kyi, Beck, Skryma, Prevarskaya (CR26) 2006; 20
Pinton, Giorgi, Siviero, Zecchini, Rizzuto (CR3) 2008; 27
Tannock, de Wit, Berry, Horti, Pluzanska, Chi (CR7) 2004; 351
Liao, Erxleben, Yildirim, Abramowitz, Armstrong, Birnbaumer (CR11) 2007; 104
Abdullaev, Bludov, Dmitriev, Kevrekidis, Konotop (CR15) 2008; 77
L Scorrano (BFcddis201052_CR1) 2003; 300
Y Gwack (BFcddis201052_CR16) 2007; 42
SR Denmeade (BFcddis201052_CR18) 1996; 28
KJ Livak (BFcddis201052_CR32) 2001; 25
V Lehen'kyi (BFcddis201052_CR31) 2007; 26
P Pinton (BFcddis201052_CR3) 2008; 27
F Vanden Abeele (BFcddis201052_CR14) 2002; 1
SR Denmeade (BFcddis201052_CR22) 2005; 4
C Peinelt (BFcddis201052_CR27) 2006; 8
SW Ng (BFcddis201052_CR13) 2008; 283
H Bonkhoff (BFcddis201052_CR19) 2001; 12
J Stiber (BFcddis201052_CR17) 2008; 10
E Norberg (BFcddis201052_CR4) 2008; 15
SL Zhang (BFcddis201052_CR10) 2005; 437
R Skryma (BFcddis201052_CR8) 2000; 527
M Potier (BFcddis201052_CR29) 2009; 23
N Prevarskaya (BFcddis201052_CR2) 2004; 322
Y Liao (BFcddis201052_CR11) 2007; 104
K Cartharius (BFcddis201052_CR21) 2005; 21
T Fixemer (BFcddis201052_CR5) 2002; 53
K Vanoverberghe (BFcddis201052_CR9) 2004; 11
F Di Sano (BFcddis201052_CR24) 2006; 281
PV Nantermet (BFcddis201052_CR20) 2004; 279
VM Gonzalez (BFcddis201052_CR23) 2001; 59
F Abdullaev (BFcddis201052_CR15) 2008; 77
JT Smyth (BFcddis201052_CR30) 2009; 11
M Muik (BFcddis201052_CR12) 2008; 283
AJ Raffo (BFcddis201052_CR6) 1995; 55
S Yang (BFcddis201052_CR28) 2009; 15
IF Tannock (BFcddis201052_CR7) 2004; 351
ST Nawrocki (BFcddis201052_CR25) 2005; 65
M Flourakis (BFcddis201052_CR26) 2006; 20
19364762 - FASEB J. 2009 Aug;23(8):2425-37
15662118 - Cancer Biol Ther. 2005 Jan;4(1):14-22
17360584 - Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4682-7
18955969 - Oncogene. 2008 Oct 27;27(50):6407-18
18806259 - J Biol Chem. 2008 Nov 14;283(46):31348-55
12242726 - Prostate. 2002 Oct 1;53(2):118-23
14576152 - J Biol Chem. 2004 Jan 9;279(2):1310-22
16611832 - FASEB J. 2006 Jun;20(8):1215-7
8602401 - Prostate. 1996 Apr;28(4):251-65
10944171 - J Physiol. 2000 Aug 15;527 Pt 1:71-83
18187424 - J Biol Chem. 2008 Mar 21;283(12):8014-22
11846609 - Methods. 2001 Dec;25(4):402-8
12086875 - Cancer Cell. 2002 Mar;1(2):169-79
14685164 - Cell Death Differ. 2004 Mar;11(3):321-30
17533368 - Oncogene. 2007 Nov 15;26(52):7380-5
16357160 - Cancer Res. 2005 Dec 15;65(24):11510-9
11259608 - Mol Pharmacol. 2001 Apr;59(4):657-63
15860560 - Bioinformatics. 2005 Jul 1;21(13):2933-42
18488020 - Nat Cell Biol. 2008 Jun;10(6):688-97
17572487 - Cell Calcium. 2007 Aug;42(2):145-56
19185847 - Cancer Cell. 2009 Feb 3;15(2):124-34
18806756 - Cell Death Differ. 2008 Dec;15(12):1857-64
16317003 - J Biol Chem. 2006 Feb 3;281(5):2693-700
11762342 - Ann Oncol. 2001;12 Suppl 2:S141-4
15336979 - Biochem Biophys Res Commun. 2004 Oct 1;322(4):1326-35
16733527 - Nat Cell Biol. 2006 Jul;8(7):771-3
19881501 - Nat Cell Biol. 2009 Dec;11(12):1465-72
16208375 - Nature. 2005 Oct 6;437(7060):902-5
18351948 - Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Jan;77(1 Pt 2):016604
7671257 - Cancer Res. 1995 Oct 1;55(19):4438-45
15470213 - N Engl J Med. 2004 Oct 7;351(15):1502-12
12624178 - Science. 2003 Apr 4;300(5616):135-9
References_xml – volume: 11
  start-page: 1465
  year: 2009
  end-page: 1472
  ident: CR30
  article-title: Phosphorylation of STIM1 underlies suppression of store-operated calcium entry during mitosis
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1995
– volume: 27
  start-page: 6407
  year: 2008
  end-page: 6418
  ident: CR3
  article-title: Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis
  publication-title: Oncogene
  doi: 10.1038/onc.2008.308
– volume: 20
  start-page: 1215
  year: 2006
  end-page: 1217
  ident: CR26
  article-title: Passive calcium leak via translocon is a first step for iPLA2-pathway regulated store operated channels activation
  publication-title: FASEB J
  doi: 10.1096/fj.05-5254fje
– volume: 42
  start-page: 145
  year: 2007
  end-page: 156
  ident: CR16
  article-title: Signalling to transcription: store-operated Ca(2+) entry and NFAT activation in lymphocytes
  publication-title: Cell Calcium
  doi: 10.1016/j.ceca.2007.03.007
– volume: 283
  start-page: 8014
  year: 2008
  end-page: 8022
  ident: CR12
  article-title: Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M708898200
– volume: 10
  start-page: 688
  year: 2008
  end-page: 697
  ident: CR17
  article-title: STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1731
– volume: 11
  start-page: 321
  year: 2004
  end-page: 330
  ident: CR9
  article-title: Ca2+ homeostasis and apoptotic resistance of neuroendocrine-differentiated prostate cancer cells
  publication-title: Cell Death Differ
  doi: 10.1038/sj.cdd.4401375
– volume: 527
  start-page: 71
  issue: Pt 1
  year: 2000
  end-page: 83
  ident: CR8
  article-title: Store depletion and store-operated Ca2+ current in human prostate cancer LNCaP cells: involvement in apoptosis
  publication-title: J Physiol
  doi: 10.1111/j.1469-7793.2000.00071.x
– volume: 23
  start-page: 2425
  year: 2009
  end-page: 2437
  ident: CR29
  article-title: Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration
  publication-title: FASEB J
  doi: 10.1096/fj.09-131128
– volume: 55
  start-page: 4438
  year: 1995
  end-page: 4445
  ident: CR6
  article-title: Overexpression of bcl-2 protects prostate cancer cells from apoptosis and confers resistance to androgen depletion
  publication-title: Cancer Res
– volume: 28
  start-page: 251
  year: 1996
  end-page: 265
  ident: CR18
  article-title: Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer
  publication-title: Prostate
  doi: 10.1002/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G
– volume: 77
  start-page: 016604
  issue: Pt 2
  year: 2008
  ident: CR15
  article-title: Generalized neighbor-interaction models induced by nonlinear lattices
  publication-title: Phys Rev E Stat Nonlin Soft Matter Phys
  doi: 10.1103/PhysRevE.77.016604
– volume: 281
  start-page: 2693
  year: 2006
  end-page: 2700
  ident: CR24
  article-title: Endoplasmic reticulum stress induces apoptosis by an apoptosome-dependent but caspase 12-independent mechanism
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M509110200
– volume: 65
  start-page: 11510
  year: 2005
  end-page: 11519
  ident: CR25
  article-title: Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-2394
– volume: 8
  start-page: 771
  year: 2006
  end-page: 773
  ident: CR27
  article-title: Amplification of CRAC current by STIM1 and CRACM1 (Orai1)
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1435
– volume: 283
  start-page: 31348
  year: 2008
  end-page: 31355
  ident: CR13
  article-title: Sustained activation of the tyrosine kinase Syk by antigen in mast cells requires local Ca2+ influx through Ca2+ release-activated Ca2+ channels
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M804942200
– volume: 21
  start-page: 2933
  year: 2005
  end-page: 2942
  ident: CR21
  article-title: MatInspector and beyond: promoter analysis based on transcription factor binding sites
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bti473
– volume: 53
  start-page: 118
  year: 2002
  end-page: 123
  ident: CR5
  article-title: Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma
  publication-title: Prostate
  doi: 10.1002/pros.10133
– volume: 1
  start-page: 169
  year: 2002
  end-page: 179
  ident: CR14
  article-title: Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(02)00034-X
– volume: 26
  start-page: 7380
  year: 2007
  end-page: 7385
  ident: CR31
  article-title: TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210545
– volume: 300
  start-page: 135
  year: 2003
  end-page: 139
  ident: CR1
  article-title: BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis
  publication-title: Science
  doi: 10.1126/science.1081208
– volume: 12
  start-page: S141
  year: 2001
  end-page: S144
  ident: CR19
  article-title: Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status
  publication-title: Ann Oncol
  doi: 10.1093/annonc/12.suppl_2.S141
– volume: 437
  start-page: 902
  year: 2005
  end-page: 905
  ident: CR10
  article-title: STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane
  publication-title: Nature
  doi: 10.1038/nature04147
– volume: 15
  start-page: 124
  year: 2009
  end-page: 134
  ident: CR28
  article-title: Orai1 and STIM1 are critical for breast tumor cell migration and metastasis
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2008.12.019
– volume: 25
  start-page: 402
  year: 2001
  end-page: 408
  ident: CR32
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 15
  start-page: 1857
  year: 2008
  end-page: 1864
  ident: CR4
  article-title: An increase in intracellular Ca2+ is required for the activation of mitochondrial calpain to release AIF during cell death
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2008.123
– volume: 279
  start-page: 1310
  year: 2004
  end-page: 1322
  ident: CR20
  article-title: Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M310206200
– volume: 104
  start-page: 4682
  year: 2007
  end-page: 4687
  ident: CR11
  article-title: Orai proteins interact with TRPC channels and confer responsiveness to store depletion
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0611692104
– volume: 351
  start-page: 1502
  year: 2004
  end-page: 1512
  ident: CR7
  article-title: Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa040720
– volume: 4
  start-page: 14
  year: 2005
  end-page: 22
  ident: CR22
  article-title: The SERCA pump as a therapeutic target: making a ‘smart bomb’ for prostate cancer
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.4.1.1505
– volume: 59
  start-page: 657
  year: 2001
  end-page: 663
  ident: CR23
  article-title: Is cisplatin-induced cell death always produced by apoptosis?
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.59.4.657
– volume: 322
  start-page: 1326
  year: 2004
  end-page: 1335
  ident: CR2
  article-title: Ca2+ homeostasis in apoptotic resistance of prostate cancer cells
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2004.08.037
– volume: 53
  start-page: 118
  year: 2002
  ident: BFcddis201052_CR5
  publication-title: Prostate
  doi: 10.1002/pros.10133
– volume: 15
  start-page: 1857
  year: 2008
  ident: BFcddis201052_CR4
  publication-title: Cell Death Differ
  doi: 10.1038/cdd.2008.123
– volume: 23
  start-page: 2425
  year: 2009
  ident: BFcddis201052_CR29
  publication-title: FASEB J
  doi: 10.1096/fj.09-131128
– volume: 20
  start-page: 1215
  year: 2006
  ident: BFcddis201052_CR26
  publication-title: FASEB J
  doi: 10.1096/fj.05-5254fje
– volume: 25
  start-page: 402
  year: 2001
  ident: BFcddis201052_CR32
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 283
  start-page: 31348
  year: 2008
  ident: BFcddis201052_CR13
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M804942200
– volume: 1
  start-page: 169
  year: 2002
  ident: BFcddis201052_CR14
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(02)00034-X
– volume: 527
  start-page: 71
  issue: Pt 1
  year: 2000
  ident: BFcddis201052_CR8
  publication-title: J Physiol
  doi: 10.1111/j.1469-7793.2000.00071.x
– volume: 279
  start-page: 1310
  year: 2004
  ident: BFcddis201052_CR20
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M310206200
– volume: 4
  start-page: 14
  year: 2005
  ident: BFcddis201052_CR22
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.4.1.1505
– volume: 15
  start-page: 124
  year: 2009
  ident: BFcddis201052_CR28
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2008.12.019
– volume: 104
  start-page: 4682
  year: 2007
  ident: BFcddis201052_CR11
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0611692104
– volume: 21
  start-page: 2933
  year: 2005
  ident: BFcddis201052_CR21
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bti473
– volume: 11
  start-page: 1465
  year: 2009
  ident: BFcddis201052_CR30
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1995
– volume: 10
  start-page: 688
  year: 2008
  ident: BFcddis201052_CR17
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1731
– volume: 12
  start-page: S141
  year: 2001
  ident: BFcddis201052_CR19
  publication-title: Ann Oncol
  doi: 10.1093/annonc/12.suppl_2.S141
– volume: 300
  start-page: 135
  year: 2003
  ident: BFcddis201052_CR1
  publication-title: Science
  doi: 10.1126/science.1081208
– volume: 77
  start-page: 016604
  issue: Pt 2
  year: 2008
  ident: BFcddis201052_CR15
  publication-title: Phys Rev E Stat Nonlin Soft Matter Phys
  doi: 10.1103/PhysRevE.77.016604
– volume: 59
  start-page: 657
  year: 2001
  ident: BFcddis201052_CR23
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.59.4.657
– volume: 351
  start-page: 1502
  year: 2004
  ident: BFcddis201052_CR7
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa040720
– volume: 11
  start-page: 321
  year: 2004
  ident: BFcddis201052_CR9
  publication-title: Cell Death Differ
  doi: 10.1038/sj.cdd.4401375
– volume: 322
  start-page: 1326
  year: 2004
  ident: BFcddis201052_CR2
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2004.08.037
– volume: 65
  start-page: 11510
  year: 2005
  ident: BFcddis201052_CR25
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-2394
– volume: 27
  start-page: 6407
  year: 2008
  ident: BFcddis201052_CR3
  publication-title: Oncogene
  doi: 10.1038/onc.2008.308
– volume: 437
  start-page: 902
  year: 2005
  ident: BFcddis201052_CR10
  publication-title: Nature
  doi: 10.1038/nature04147
– volume: 281
  start-page: 2693
  year: 2006
  ident: BFcddis201052_CR24
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M509110200
– volume: 26
  start-page: 7380
  year: 2007
  ident: BFcddis201052_CR31
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210545
– volume: 55
  start-page: 4438
  year: 1995
  ident: BFcddis201052_CR6
  publication-title: Cancer Res
– volume: 28
  start-page: 251
  year: 1996
  ident: BFcddis201052_CR18
  publication-title: Prostate
  doi: 10.1002/(SICI)1097-0045(199604)28:4<251::AID-PROS6>3.0.CO;2-G
– volume: 42
  start-page: 145
  year: 2007
  ident: BFcddis201052_CR16
  publication-title: Cell Calcium
  doi: 10.1016/j.ceca.2007.03.007
– volume: 283
  start-page: 8014
  year: 2008
  ident: BFcddis201052_CR12
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M708898200
– volume: 8
  start-page: 771
  year: 2006
  ident: BFcddis201052_CR27
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1435
– reference: 16208375 - Nature. 2005 Oct 6;437(7060):902-5
– reference: 15336979 - Biochem Biophys Res Commun. 2004 Oct 1;322(4):1326-35
– reference: 16733527 - Nat Cell Biol. 2006 Jul;8(7):771-3
– reference: 17533368 - Oncogene. 2007 Nov 15;26(52):7380-5
– reference: 18955969 - Oncogene. 2008 Oct 27;27(50):6407-18
– reference: 15470213 - N Engl J Med. 2004 Oct 7;351(15):1502-12
– reference: 18187424 - J Biol Chem. 2008 Mar 21;283(12):8014-22
– reference: 14576152 - J Biol Chem. 2004 Jan 9;279(2):1310-22
– reference: 17360584 - Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4682-7
– reference: 15860560 - Bioinformatics. 2005 Jul 1;21(13):2933-42
– reference: 17572487 - Cell Calcium. 2007 Aug;42(2):145-56
– reference: 11846609 - Methods. 2001 Dec;25(4):402-8
– reference: 16611832 - FASEB J. 2006 Jun;20(8):1215-7
– reference: 16357160 - Cancer Res. 2005 Dec 15;65(24):11510-9
– reference: 18806756 - Cell Death Differ. 2008 Dec;15(12):1857-64
– reference: 12242726 - Prostate. 2002 Oct 1;53(2):118-23
– reference: 14685164 - Cell Death Differ. 2004 Mar;11(3):321-30
– reference: 18488020 - Nat Cell Biol. 2008 Jun;10(6):688-97
– reference: 18351948 - Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Jan;77(1 Pt 2):016604
– reference: 19185847 - Cancer Cell. 2009 Feb 3;15(2):124-34
– reference: 11259608 - Mol Pharmacol. 2001 Apr;59(4):657-63
– reference: 8602401 - Prostate. 1996 Apr;28(4):251-65
– reference: 15662118 - Cancer Biol Ther. 2005 Jan;4(1):14-22
– reference: 19364762 - FASEB J. 2009 Aug;23(8):2425-37
– reference: 12086875 - Cancer Cell. 2002 Mar;1(2):169-79
– reference: 7671257 - Cancer Res. 1995 Oct 1;55(19):4438-45
– reference: 10944171 - J Physiol. 2000 Aug 15;527 Pt 1:71-83
– reference: 16317003 - J Biol Chem. 2006 Feb 3;281(5):2693-700
– reference: 18806259 - J Biol Chem. 2008 Nov 14;283(46):31348-55
– reference: 11762342 - Ann Oncol. 2001;12 Suppl 2:S141-4
– reference: 19881501 - Nat Cell Biol. 2009 Dec;11(12):1465-72
– reference: 12624178 - Science. 2003 Apr 4;300(5616):135-9
SSID ssj0000330256
Score 2.3560197
Snippet The molecular nature of calcium (Ca 2+ )-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of...
The molecular nature of calcium (Ca(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of...
The molecular nature of calcium (Ca2+ )-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject of...
The molecular nature of calcium (Ca super(2+))-dependent mechanisms and the ion channels having a major role in the apoptosis of cancer cells remain a subject...
SourceID pubmedcentral
hal
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e75
SubjectTerms 631/45/269/1146
631/80/304
631/80/82/23
692/699/67/589/466
Amino Acid Substitution
Antibodies
Antineoplastic Agents - therapeutic use
Apoptosis
Biochemistry
Biomedical and Life Sciences
Calcium - metabolism
Calcium Channels - genetics
Calcium Channels - metabolism
Calcium Channels - physiology
Cell Biology
Cell Culture
Cell Line, Tumor
Cisplatin - therapeutic use
Humans
Immunology
Life Sciences
Male
Membrane Proteins - metabolism
Mutation
Neoplasm Proteins - metabolism
ORAI1 Protein
Original
original-article
Phenotype
Prostatic Neoplasms - drug therapy
Prostatic Neoplasms - metabolism
Stromal Interaction Molecule 1
Thapsigargin - therapeutic use
Tumor Necrosis Factor-alpha - therapeutic use
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9VAEB5speCLqPUSrbItYl8MTTbZS56kiOUgtr5UOG9hb6EHJIknqeC_dybJST3W-podyGZndufbmS8zAG-tN9r4okDjNTzObW4ov1vEJnDpqoy6wFG84_xCLr7ln5diOQXcuolWuTkTh4PaN45i5Cep0lRFVXDxof0RU9coyq5OLTR24D6VLiOrVks1x1gSvKyjS59KayaZPnFE0hkJXYJvuaKdKyJC3kaZt8mSf2VMB0d09ggeTgiSnY4qfwz3Qv0E9saekr_2wX1dm1XKBgo69bIKHesbhjCP4fvMEHOigCBrKmZqZtqm7Ztu1cV47SYoiSPE-mooNMtWNWvprxDEo8yReawZBfq7p3B59uny4yKeOinETvCkj23Kg7Kp9aGSCQ8OQaCwUggj8cJUBcWt1AGVabnyeAfzqS6sqrzSQXsEGNkz2K2bOrwAJrnzQQVrnLK5D8ZqYZRDFGild0XCI3i_WdPSTVXGqdnF93LIdme6HFRQkgpKgeLvZvF2LK9xl-ARKmiWoaLYi9MvJT2jimEcj5mfaQQHG_2V01bsyhvDieBwHsZNRAtm6tBck0xBrW-kKCJgd8hogUupEF1H8Hy0iHk2PM0kOhwdgdqyla3pbo_Uq6uhljciCJ7lKoLjjVX9MfN_LcTL_3_jK3gw8huIBXcAu_36OrxG2NTbN8Pe-A2Q5xt2
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9VAEB5qi-CLWOslvchaRF8MJpvsJY8HsRwOVR-s0Lewt9ADkhxOUsF_70ySE4y14Gt2Qpad2d1vZ798A_DGeqONLwoMXsPj3OaG7neL2AQuXZVRFTjKd3z-Ipff89W1uB5_Vm9HWuUgadkv0zt22AdH7JqBiSVwxT0glXYM64PFYvVtNSVVEjyd4x4-amkmmZ6_N9t7HtwQ8_EurLzLjvzrirTfeS6ewOMRMrLF0MlD2Av1U3g4FJH8dQTu69asU9Zzzql4VWhZ1zDEdQy_Z_okE2UAWVMxUzOzaTZd067bGM_ZhB2xhWheDeVi2bpmG_oNBAEocxQPW0aZ_fYZXF18uvq4jMfSCbETPOlim_KgbGp9qGTCg0PUJ6wUwkg8IVVBcSt1QO9ZrjweunyqC6sqr3TQHhFF9hz266YOL4FJ7nxQwRqnbO6DsVoY5RD2WeldkfAI3u_GtHSjrDhVt_hR9tfbmS57F5TkglKg-dvJfDPoadxneI4OmmxIBXu5uCzpGUmEcVxXfqYRnO78V45zry1TpUlvV3ARweupGWcNDZipQ3NLNgXVupGiiIDdY6MFDqVCOB3BiyEipt7wNJO4w-gI1CxWZt2dt9Trm168GyEDz3IVwbtdVP3R838NxPF_W57Ao4HbQAy4U9jvtrfhDCFTZ1-NE-U38XMZxw
  priority: 102
  providerName: Springer Nature
Title Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells
URI https://link.springer.com/article/10.1038/cddis.2010.52
https://www.ncbi.nlm.nih.gov/pubmed/21364678
https://www.proquest.com/docview/1786539525
https://www.proquest.com/docview/1790961659
https://www.proquest.com/docview/855207020
https://hal.science/hal-04122793
https://pubmed.ncbi.nlm.nih.gov/PMC3032347
Volume 1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEF9si-CL-G20HquIvhh72WQ_8iByHi3HYatoC_cW9iv0oCTnJRX73zuzyZ2e14JPB9kht8zM7v5mdvIbQl4bp5V2eQ7Oq1mcmUzj_W4ea8-ELVPsAof5juMTMTnLpjM--0Mp1CuwuTa0w35SZ8uL979-XH2EBf-h-2RcHVisvOmqtDjsxntwKElsZnDcI_2wKUPczkIvVzbMIGpSKu8ZN7feEPiBUwE7iNo4rHbOsVRyG4dul1P-c6cajqqje-RujzHpqHOK--SWrx6Q213XyauHxH5Z6nlCQ5E6drvyDW1rCkCQwv_pkJXClCGtS6orqhf1oq2beRNDYI5gE0awLqzG5C2dV3SB340AYqUWHWhJ8SqgeUROjw5Px5O477UQW86GbWwS5qVJjPOlGDJvASZyIzjXAkKq0ktmhPJgbsOkgyjNJSo3snRSeeUAgqSPyW5VV_4poYJZ56U32kqTOa-N4lpawIlGOJsPWUTerXRa2J6HHNthXBThPjxVRbBGgdYoOIi_WYsvOgKOmwRfgYHWMkibPRl9LvAZcoox2Ih-JhHZX9mvWPlakUiFBL2c8Yi8XA_DMkOF6crXlyiTY3McwfOI0BtkFAdVSsDfEXnSecR6NiuHiojc8JWN6W6OVPPzwPYNGIOlmYzI25VX_TXz6xTx7H8U8Zzc6eogsFpun-y2y0v_AuBVawZkR87kgOyNRtPvU_j9dHjy9Rs8HYvxIKQsBmFp_QadPyml
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB61RQguiDeGAgviccGqvc561weEKqBKaVouQcrN2pfVSJWdxi6oP4r_yIwfgVDKrdfsyFnPzO588_AMwCvjtNIuy1B5NQ9HZqQpv5uF2vPUFglNgaN4x-FROv42-jITsw34OXwLQ2WVw53YXtSushQj34mloi6qgosPi9OQpkZRdnUYodGpxYE__4EuW_1-_xPK9zXne5-nH8dhP1UgtIJHTWhi7qWJjfNFGnFvERAJkwqhU3QeCi-5SZXHFzNcOvRHXKwyIwsnlVcOjW2Cj92Ea2h3I_L15EyuQjpRkhCC6Dt5RonasVQT1NWPCb5m-TaPqe7yIqi9WJv5V4K2tXt7t-FWD1jZbqdhd2DDl3fhejfC8vwe2K9LPY9ZW_FOo7N8zZqKIapk-H-6DXFR_JFVBdMl04tq0VT1vA7RyyfkiitUZFZRJJjNS7agj1AQ_jJL2rhklFeo78P0Klj8ALbKqvSPgKXcOi-90VaakfPaKKGlRdBpUmeziAfwbuBpbvum5jRb4yRvk-uJylsR5CSCXCD5mxX5ouvmcRnhSxTQioZ6cI93Jzn9Rg3KON5q3-MAtgf55f3Jr_PfehrAi9UynllimC59dUY0GU3aSUUWALuERglkpUQwH8DDTiNWu-FxkqJ9UwHINV1Z2-76Sjk_bluHI2DhyUgG8HbQqj92_i9GPP7_Oz6HG-Pp4SSf7B8dPIGbXWkFFeBtw1azPPNPEbE15ll7ThjkV3wufwG621iF
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB61qUBcEG9cCiyIxwUr8TrrXR8QKrRRSkuoUJF6s_ZlNRKy0zgF9afx75jxIxBKufWaHTnrmdndb2c-zwC8ME4r7dIUnVfzcGiGmvK7aag9T2weUxc4ind8miTjr8OPx-J4DX5238IQrbLbE-uN2pWWYuT9SCqqoiq46OctLeJwZ_RudhpSBynKtHbtNBoX2ffnP_D6Vr3d20Fbv-R8tHv0YRy2HQZCK_hgEZqIe2ki43yeDLi3CI6ESYTQCV4kci-5SZTHlzRcOrybuEilRuZOKq8cHrwxPnYdNiRdinqw8X53cvhlGeAZxDHhibau5yBWfUsMoYZNJvjKObh-QizMixD3IlPzr3RtfQqObsHNFr6y7cbfbsOaL-7Ataah5fldsJ_nehqxmv9OjbR8xRYlQ4zJ8P90HfCiaCQrc6YLpmflbFFW0yrEOz_hWBwhyllJcWE2LdiMPklBMMws-eacUZahugdHV6Hk-9ArysI_BJZw67z0Rltphs5ro4SWFiGoSZxNBzyAN51OM9uWOKdOG9-yOtUeq6w2QUYmyASKv1qKz5raHpcJPkcDLWWoIvd4-yCj36hcGcc97nsUwFZnv6zdB6rst9cG8Gw5jCuYFKYLX56RTEp9dxKRBsAukVECVSkR2gfwoPGI5Wx4FCd42qkA5IqvrEx3daSYntSFxBG-8HgoA3jdedUfM_-XIjb__45P4Tquyexgb7L_CG40PAti421BbzE_848Rvi3Mk3ahMMiueGn-AlFfXiA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Orai1+contributes+to+the+establishment+of+an+apoptosis-resistant+phenotype+in+prostate+cancer+cells&rft.jtitle=Cell+death+%26+disease&rft.au=Flourakis%2C+M&rft.au=Lehen%27Kyi%2C+V&rft.au=Beck%2C+B&rft.au=Rapha%C3%ABl%2C+M&rft.date=2010-09-01&rft.pub=Nature+Publishing+Group&rft.issn=2041-4889&rft.eissn=2041-4889&rft.volume=1&rft.issue=9&rft.spage=e75&rft.epage=e75&rft_id=info:doi/10.1038%2Fcddis.2010.52&rft_id=info%3Apmid%2F21364678&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai_HAL_hal_04122793v1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-4889&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-4889&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-4889&client=summon